Zefei Jiang Selected Research

pegylated granulocyte colony-stimulating factor

5/2020	Erratum to efficacy and safety of mecapegfilgrastim for prophylaxis of chemotherapy-induced neutropenia in patients with breast cancer: a randomized, multicenter, active-controlled phase III trial.
9/2019	Efficacy and safety of mecapegfilgrastim for prophylaxis of chemotherapy-induced neutropenia in patients with breast cancer: a randomized, multicenter, active-controlled phase III trial.
5/2019	A randomized multicenter phase II trial of mecapegfilgrastim single administration versus granulocyte colony-stimulating growth factor on treating chemotherapy-induced neutropenia in breast cancer patients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Zefei Jiang Research Topics

Disease

70	Breast Neoplasms (Breast Cancer) 01/2022 - 12/2000
26	Neoplasms (Cancer) 01/2022 - 09/2003
13	Neoplasm Metastasis (Metastasis) 01/2022 - 01/2014
8	Disease Progression 12/2022 - 11/2009
8	Neutropenia 05/2020 - 08/2012
5	Triple Negative Breast Neoplasms 12/2022 - 10/2014
5	Diarrhea 01/2021 - 03/2010
3	Circulating Neoplastic Cells 01/2022 - 04/2013
3	Hand-Foot Syndrome 01/2020 - 08/2012
2	Pathologic Complete Response 08/2020 - 01/2020
2	Lymphatic Metastasis 05/2018 - 09/2014
2	Exanthema (Rash) 11/2017 - 01/2017
2	Stomatitis 11/2017 - 07/2015
2	Cardiotoxicity 12/2014 - 03/2010
1	Ductal Carcinoma 10/2021
1	Precursor B-Cell Lymphoblastic Leukemia-Lymphoma (Leukemia, Pre B Cell) 07/2021
1	COVID-19 01/2021
1	Thrombocytopenia (Thrombopenia) 01/2021
1	Nausea 01/2021
1	Multiple Myeloma 06/2020
1	Dyspnea (Shortness of Breath) 11/2019
1	Febrile Neutropenia 05/2019
1	Hyperglycemia 11/2018
1	Pain (Aches) 01/2017
1	Peripheral Nervous System Diseases (PNS Diseases) 01/2017

Drug/Important Bio-Agent (IBA)

18	Trastuzumab (Herceptin)FDA Link 01/2021 - 11/2009
12	Hormones (Hormone)IBA 05/2021 - 01/2014
9	AnthracyclinesIBA 10/2021 - 12/2010
8	Estrogen ReceptorsIBA 01/2022 - 02/2007
7	Proteins (Proteins, Gene)FDA Link 07/2021 - 09/2003
7	Lapatinib (GW572016)FDA Link 01/2021 - 06/2013
6	Capecitabine (Xeloda)FDA Link 03/2020 - 08/2012
6	ErbB Receptors (EGF Receptor)IBA 11/2018 - 03/2010
6	Paclitaxel (Taxol)FDA LinkGeneric 11/2017 - 12/2010
5	Fulvestrant (Faslodex)FDA Link 11/2019 - 01/2011
4	Gemcitabine FDA Link 12/2022 - 12/2010
4	Pharmaceutical PreparationsIBA 07/2021 - 07/2011
4	Taxoids (Taxanes)IBA 10/2019 - 03/2012
4	Biomarkers (Surrogate Marker)IBA 01/2018 - 04/2013
3	Cisplatin (Platino)FDA LinkGeneric 12/2022 - 07/2011
3	Epidermal Growth Factor (EGF)IBA 01/2021 - 01/2017
3	human ERBB2 proteinIBA 01/2021 - 01/2019
3	pertuzumabIBA 01/2021 - 01/2019
3	pegylated granulocyte colony-stimulating factorIBA 05/2020 - 05/2019
3	Docetaxel (Taxotere)FDA Link 01/2020 - 08/2012
3	Alanine Transaminase (SGPT)IBA 01/2020 - 01/2017
3	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2020 - 01/2017
3	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 11/2018 - 07/2014
3	Progesterone Receptors (Progesterone Receptor)IBA 05/2018 - 01/2014
3	taxaneIBA 01/2017 - 03/2012
2	Transcription Factors (Transcription Factor)IBA 07/2021 - 02/2007
2	pyrotinibIBA 01/2021 - 10/2019
2	Diphosphonates (Bisphosphonates)IBA 06/2020 - 01/2017
2	Vinorelbine (Navelbine)FDA LinkGeneric 01/2020 - 08/2012
2	apatinibIBA 01/2020 - 10/2014
2	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 05/2019 - 12/2000
2	exemestane (Aromasin)FDA Link 01/2019 - 12/2018
2	Therapeutic UsesIBA 01/2019 - 11/2017
2	NVP-BKM120IBA 11/2018 - 01/2017
2	Everolimus FDA Link 11/2017 - 07/2015
2	Aromatase InhibitorsIBA 01/2017 - 12/2014
1	130-nm albumin-bound paclitaxelIBA 12/2022
1	PlatinumIBA 12/2022
1	Cannabinoid Receptors (Cannabinoid Receptor)IBA 07/2021
1	1,1-dimethyl-4-acetylpiperaziniumIBA 07/2021
1	RimonabantIBA 07/2021
1	Phosphotransferases (Kinase)IBA 07/2021
1	Oncogene Proteins (Oncogene Protein)IBA 07/2021
1	Green Fluorescent ProteinsIBA 07/2021
1	Ado-Trastuzumab EmtansineIBA 01/2021
1	Denosumab FDA Link 06/2020
1	tributyl phosphate (TBP)IBA 03/2020
1	Immune Checkpoint InhibitorsIBA 01/2020
1	Epirubicin (Ellence)FDA LinkGeneric 01/2020
1	B7-H1 AntigenIBA 01/2020
1	camrelizumabIBA 01/2020
1	Filgrastim (Neupogen)FDA Link 09/2019
1	Immunoglobulin G (IgG)IBA 09/2019
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 05/2019
1	Estradiol (Delestrogen)FDA LinkGeneric 01/2019
1	Follicle Stimulating Hormone (Follitropin)FDA Link 01/2019
1	Histone Deacetylases (Histone Deacetylase)IBA 12/2018
1	Histone Deacetylase InhibitorsIBA 12/2018
1	N- (2- amino- 5- fluorobenzyl)- 4- (N- (pyridine- 3- acrylyl)aminomethyl)benzamideIBA 12/2018
1	Transfer RNA (tRNA)IBA 01/2018
1	Small Untranslated RNAIBA 01/2018
1	Ibandronic Acid (Boniva)FDA Link 01/2017
1	Epothilones (Epothilone)IBA 01/2017
1	N(4)-chloroacetylcytosine arabinoside (CACA)IBA 10/2015

Therapy/Procedure

36	Therapeutics 01/2022 - 11/2009
23	Drug Therapy (Chemotherapy) 10/2021 - 11/2009
6	Neoadjuvant Therapy 01/2021 - 07/2014
3	Adjuvant Chemotherapy 09/2019 - 11/2009
3	Combination Drug Therapy (Combination Chemotherapy) 08/2012 - 12/2000
1	Mastectomy (Mammectomy) 10/2021
1	Lymph Node Excision (Lymph Node Dissection) 10/2021
1	Radiotherapy 01/2021
1	Duration of Therapy 09/2019
1	Intravenous Infusions 01/2019
1	Aftercare (After-Treatment) 01/2017